Learning From the Past & Spearheading Macrophage Clinical Acceleration The 6th Macrophage-Directed Therapies Summit is uniting 60+ biopharma and academia leaders across R&D, Discovery, Biology, Translational, and Clinical Development fields for invaluable networking and insights into all facets of macrophage-directed therapies. Grab your Full Agenda – https://ter.li/nqf2qd Despite toxicity concerns for CD47 targets in 2023, […]

With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment. Introducing the 4th iPSC Drug Development & Manufacturing Summit, your longest standing and definitive iPSC focused platform. No iPSC stone will be […]

SAE Media Group’s 5th Annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and digital health applications for wearable devices with industry perspectives from big pharma representatives. The conference will consider key developments in the wearable injectors field, including the enhanced […]

Are you listening to your patient community? It’s not enough. Standing in the shadows and harvesting anecdotal insights won’t build connections, create first-hand knowledge or illuminate your impact to internal stakeholders. We must step forward and be visible, actively engaging in patient communities and embedding the patient voice internally. YOU are the patient advocate in […]

The 5th Commercializing Flow Chemistry Summit marks a pivotal year, introducing a significant shift in content to address the evolving needs of the pharmaceutical manufacturing industry. This summit zeroes in on advanced scale-up capabilities and stakeholder engagement strategies, responding to a market that is rapidly expanding and forecasted to reach US $4.6 billion by 2032. […]

Following the watershed approval of Iovance’s Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment. Introducing the 6th Annual TIL Therapies Summit! With 30+ expert speakers, 12 new speaker companies, 2 brand-new content-filled tracks and 2 brand-new interactive workshops, you won't want to miss out! Hear […]

With a flurry of high capital collaborations and partnership deals from the likes of C4T, Merck KgGA, Monte Rosa, Proxygen, Orum, and momentum building in clinic with BTK degraders, ER degraders and many more assets. It has never been more import to re-join forces at the 7th TPD & Induced Proximity Summit, the longest standing and most comprehensive protein degradation and proximity based […]

𝘞𝘢𝘯𝘵 𝘵𝘰 𝘜𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥 𝘎𝘶𝘪𝘥𝘢𝘯𝘤𝘦, 𝘚𝘵𝘳𝘦𝘢𝘮𝘭𝘪𝘯𝘦 𝘚𝘶𝘣𝘮𝘪𝘴𝘴𝘪𝘰𝘯𝘴, & 𝘖𝘣𝘵𝘢𝘪𝘯 𝘈𝘱𝘱𝘳𝘰𝘷𝘢𝘭? The knowledge and connections you gain at the 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 will make the difference between success and delay in your IND and BLA applications. You'll hear from top regulatory experts like David Uguen (𝗢𝗿𝗰𝗵𝗮𝗿𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀), Shirley Bartido (𝗧𝗮𝗸𝗲𝗱𝗮 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀), Yao-Yao Zhu […]

Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace. The 6th Gene Therapy Analytical Development & CMC Summit […]